Aryl triazines as LPAAT-β inhibitors and uses thereof
US7291616B2 · kind B2 · utility
9Cited by
19References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2002 |
| Grant date | Nov 6, 2007 |
| Priority date | — |
| Expiry date | Jun 19, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity and/or proliferation of cells such as tumor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.